A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Abroad (travel likely)RecruitingPHASE1

Conditions

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer) · CRC (Colorectal Cancer) · Advanced Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Research Site, Orlando, Florida, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, St Louis, Missouri, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, Durham, North Carolina, United States

  • Research Site, Nashville, Tennessee, United States

  • Research Site, Houston, Texas, United States

  • Research Site #2, San Antonio, Texas, United States

  • Research Site, San Antonio, Texas, United States

  • Research Site, Fairfax, Virginia, United States

Study leads
  • Study Medical Director

    Study Director

    Alterome Therapeutics